Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is estradiol a genotoxic mutagenic carcinogen?

J G Liehr1

  • 1Stehlin Foundation for Cancer Research, Houston, Texas 77003, USA. jliehr@mindspring.com

Endocrine Reviews
|March 4, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Specific binding of 4-hydroxyestradiol to mouse uterine protein: evidence of a physiological role for 4-hydroxyestradiol.

The Journal of endocrinology·2005
Same author

Role of estrogen in alcohol promotion of breast cancer and prolactinomas.

Alcoholism, clinical and experimental research·2001
Same author

Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development.

Human reproduction update·2001
Same author

Role of iron in estrogen-induced cancer.

Current medicinal chemistry·2001
Same author

Pharmacology of camptothecin esters.

Annals of the New York Academy of Sciences·2001
Same author

Combined radiation and 9-nitrocamptothecin (rubitecan) in the treatment of locally advanced pancreatic cancer.

Annals of the New York Academy of Sciences·2001

The natural hormone 17 beta-estradiol (E2) can cause tumors by promoting cell proliferation and inducing genetic damage. This hormone acts as a weak carcinogen, initiating cancer development through DNA lesions and cell growth.

Area of Science:

  • Endocrinology
  • Cancer Biology
  • Genetics

Background:

  • 17 beta-estradiol (E2), a natural hormone, is linked to tumor development in various animal models and increased cancer risk in humans.
  • Estrogen's role in carcinogenesis is complex, involving both cell proliferation and direct genetic damage.
  • Epigenetic mechanisms have been proposed, but recent evidence points to estrogen as a procarcinogen.

Purpose of the Study:

  • To investigate the dual role of estrogen in carcinogenesis.
  • To explore the mechanisms by which estrogen induces genetic damage and promotes tumor development.
  • To understand how hormone-driven cell proliferation interacts with genetic lesions.

Main Methods:

  • Review of existing literature on estrogen's carcinogenic effects.

Related Experiment Videos

  • Analysis of studies on metabolic conversion of E2 to reactive intermediates (e.g., 4-hydroxyestradiol).
  • Examination of data on DNA damage, chromosomal aberrations, and gene mutations induced by E2 and its metabolites in various test systems.

    • Main Results:

    • Estrogen (E2) can be metabolically converted to reactive intermediates that cause DNA damage via free radical mechanisms.
    • E2 induces genetic lesions, including aneuploidy, chromosomal aberrations, gene amplification, and microsatellite instability.
    • E2 is identified as a weak carcinogen and mutagen, inducing genetic lesions at low frequencies.

    Conclusions:

    • Estrogen (E2) possesses a dual role in cancer, stimulating cell proliferation and acting as a procarcinogen.
    • Tumorigenesis may result from the proliferation of cells with E2-induced genetic damage, mediated by hormone receptors.
    • E2's ability to induce genetic lesions, albeit at low frequency, contributes to its carcinogenic potential.